FI853140A0 - Etylendiaminmonoamid-derivat. - Google Patents

Etylendiaminmonoamid-derivat.

Info

Publication number: FI853140A0
Authority: FI; Finland
Prior art keywords: etylendiaminmonoamid; derivate
Prior art date: 1984-08-29

Application number

FI853140A

Other languages

English (en)

Other versions

FI83511C (fi

FI83511B (fi

FI853140L (fi

Inventor

Rene Imhof

Emilio Kyburz

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-08-29

Filing date

1985-08-15

Publication date

1985-08-15

1984-08-29 Priority claimed from CH4132/84A external-priority patent/CH661043A5/de

1985-06-05 Priority claimed from CH2404/85A external-priority patent/CH664755A5/de

1985-08-15 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1985-08-15 Publication of FI853140A0 publication Critical patent/FI853140A0/fi

1986-03-01 Publication of FI853140L publication Critical patent/FI853140L/fi

1991-04-15 Application granted granted Critical

1991-04-15 Publication of FI83511B publication Critical patent/FI83511B/fi

1991-07-25 Publication of FI83511C publication Critical patent/FI83511C/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Hydrogenated Pyridines (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Thiazole And Isothizaole Compounds (AREA)
Furan Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Medicinal Preparation (AREA)
Pyrrole Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

FI853140A 1984-08-29 1985-08-15 Foerfarande foer framstaellning av farmakologiskt aktiva etylendiaminmonoamidderivat. FI83511C (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
CH413284		1984-08-29
CH4132/84A CH661043A5 (en)	1984-08-29	1984-08-29	Ethylenediamine monoamide derivatives
CH240485		1985-06-05
CH2404/85A CH664755A5 (de)	1985-06-05	1985-06-05	Aethylendiaminmonoamid-derivat.

Publications (4)

Publication Number	Publication Date
FI853140A0 true FI853140A0 (fi)	1985-08-15
FI853140L FI853140L (fi)	1986-03-01
FI83511B FI83511B (fi)	1991-04-15
FI83511C FI83511C (fi)	1991-07-25

Family

ID=25690366

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI853140A FI83511C (fi)	1984-08-29	1985-08-15	Foerfarande foer framstaellning av farmakologiskt aktiva etylendiaminmonoamidderivat.

Country Status (28)

Country	Link
US (1)	US4764522A (fi)
JP (2)	JPH0764817B2 (fi)
KR (1)	KR920007269B1 (fi)
AR (1)	AR244209A1 (fi)
AT (1)	AT391694B (fi)
AU (1)	AU582381B2 (fi)
BE (1)	BE903110A (fi)
BG (1)	BG60401B1 (fi)
CA (1)	CA1261335A (fi)
DE (1)	DE3530046C2 (fi)
DK (1)	DK162888C (fi)
ES (2)	ES8705372A1 (fi)
FI (1)	FI83511C (fi)
FR (1)	FR2569694B1 (fi)
GB (1)	GB2163746B (fi)
GR (1)	GR852071B (fi)
HU (1)	HU197309B (fi)
IE (1)	IE58788B1 (fi)
IL (1)	IL76176A (fi)
IT (1)	IT1190385B (fi)
LU (1)	LU86049A1 (fi)
MC (1)	MC1696A1 (fi)
NL (1)	NL193583C (fi)
NO (1)	NO169711C (fi)
NZ (1)	NZ213193A (fi)
PH (1)	PH22813A (fi)
PT (1)	PT81041B (fi)
SE (1)	SE464083B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5204482A (en) *	1988-07-28	1993-04-20	Hoffman-Laroche Inc.	Compounds for treating and preventing cognitive diseases and depression and methods of making same
EP0352581A3 (de) *	1988-07-28	1990-07-04	F. Hoffmann-La Roche Ag	Aethylendiaminmonoamid-Derivate
CA2245055C (en) *	1989-02-28	2003-03-25	F. Hoffmann-La Roche Ag	Amidation of pyridines
EP0451790A1 (de) *	1990-04-12	1991-10-16	Hoechst Aktiengesellschaft	3,5-disubstituierte 2-Isoxazoline und Isoxazole, Verfahren zu deren Herstellung, diese enthaltende Mittel und ihre Verwendung
JPH04295470A (ja) *	1991-03-22	1992-10-20	Wakamoto Pharmaceut Co Ltd	モノアミンオキシダーゼ−ｂ酵素阻害活性を有する１，２，４−オキサジアゾール誘導体及びその製造法
US5545658A (en) *	1991-03-26	1996-08-13	Hoffman-La Roche Inc.	Amino acid derivatives
RU2097378C1 (ru) *	1991-03-26	1997-11-27	Ф.Хоффманн-Ля Рош Аг	ПРОИЗВОДНЫЕ N-АЦИЛ- α -АМИНОКИСЛОТЫ ИЛИ ИХ ФИЗИОЛОГИЧЕСКИ ПРИЕМЛЕМЫЕ СОЛИ, ПРОСТЫЕ ИЛИ СЛОЖНЫЕ ЭФИРЫ, АМИДЫ ИЛИ ГИДРАТЫ И КОМПОЗИЦИЯ ИНГИБИРУЮЩАЯ СВЯЗЫВАНИЕ АДГЕЗИВНЫХ ПРОТЕИНОВ С ТРОМБОЦИТАМИ И АГРЕГАЦИЮ ТРОМБОЦИТОВ
FR2803592A1 (fr) *	2000-01-06	2001-07-13	Aventis Cropscience Sa	Nouveaux derives de l'acide 3-hydroxypicolinique, leur procede de preparation et compositions fongicides les contenant.
CA2467689C (en) *	2001-12-06	2013-10-01	Fibrogen, Inc.	Stabilization of hypoxia inducible factor (hif) alpha using inhibitors of hif prolyl hydroxylase
US6667327B2 (en)	2002-02-04	2003-12-23	Hoffmann-La Roche Inc.	Pyridine amido derivatives
WO2005039591A1 (en) *	2003-10-23	2005-05-06	F. Hoffmann-La Roche Ag	Benzazepine derivatives as mao-b inhibitors
WO2007008963A1 (en) *	2005-07-13	2007-01-18	Jenrin Discovery	Mao-b inhibitors useful for treating obesity
WO2008010796A1 (en) *	2006-07-18	2008-01-24	Renaissance Medicine, Llc	Process for preparing pyridine-2-carboxamides and intermediates therefor
WO2008010794A1 (en) *	2006-07-18	2008-01-24	Renaissance Medicine, Llc	Pharmaceutical preparations of crystalline lazabemide
FR2904317A1 (fr) *	2006-07-27	2008-02-01	Inst Nat Sante Rech Med	Analogues d'halogenobenzamides marques a titre de radiopharmaceutiques
EP2085390A1 (en)	2008-01-31	2009-08-05	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
WO2011028740A1 (en) *	2009-09-03	2011-03-10	Glaxo Group Limited	ENaC BLOCKERS
NZ753905A (en) *	2013-06-13	2020-07-31	Akebia Therapeutics Inc	Compositions and methods for treating anemia
EP3277270B1 (en)	2015-04-01	2021-10-27	Akebia Therapeutics, Inc.	Compositions and methods for treating anemia
WO2019028150A1 (en)	2017-08-01	2019-02-07	Akebia Therapeutics, Inc.	COMPOSITIONS FOR USE IN METHODS OF TREATING HEMOGLOBINOPATHIES

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB451304A (en) *	1934-07-07	1936-08-04	Karl Merck	Process for the manufacture of new derivatives of pyrazinemonocarboxylic acid
DE1217385B (de) *	1962-11-09	1966-05-26	J. R. Geigy A.-G., Basel (Schweiz)	Verfahren zur Herstellung von neuen Picolinsäurederivafen
NL6707566A (fi) *	1966-08-17	1968-02-19
US4041032A (en) *	1974-01-16	1977-08-09	Yamanouchi Pharmaceutical Co., Ltd.	Pyrazine derivatives
GB1521471A (en) *	1974-06-05	1978-08-16	Randall & Son Ltd J	Token-deposit locks
GB1509300A (en) *	1975-12-05	1978-05-04	Ici Ltd	Ethanolamine derivatives
DE3239573A1 (de) *	1981-10-28	1983-05-19	Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz	Substituierte picolinsaeuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel
IE54220B1 (en) *	1981-12-23	1989-07-19	Ici Plc	Phenol esters
CH653670A5 (de) *	1983-03-03	1986-01-15	Hoffmann La Roche	Benzamid-derivate.

1985
- 1985-07-17 CA CA000486984A patent/CA1261335A/en not_active Expired
- 1985-08-05 IT IT21865/85A patent/IT1190385B/it active
- 1985-08-15 FI FI853140A patent/FI83511C/fi not_active IP Right Cessation
- 1985-08-16 US US06/766,364 patent/US4764522A/en not_active Expired - Lifetime
- 1985-08-21 LU LU86049A patent/LU86049A1/de unknown
- 1985-08-22 DE DE3530046A patent/DE3530046C2/de not_active Expired - Lifetime
- 1985-08-22 NZ NZ213193A patent/NZ213193A/xx unknown
- 1985-08-23 BE BE0/215498A patent/BE903110A/fr not_active IP Right Cessation
- 1985-08-23 IL IL76176A patent/IL76176A/xx not_active IP Right Cessation
- 1985-08-26 AU AU46636/85A patent/AU582381B2/en not_active Expired
- 1985-08-26 HU HU853224A patent/HU197309B/hu not_active IP Right Cessation
- 1985-08-27 KR KR1019850006181A patent/KR920007269B1/ko not_active Expired
- 1985-08-27 AR AR85301429A patent/AR244209A1/es active
- 1985-08-27 GR GR852071A patent/GR852071B/el unknown
- 1985-08-27 FR FR858512792A patent/FR2569694B1/fr not_active Expired - Lifetime
- 1985-08-27 MC MC851793A patent/MC1696A1/xx unknown
- 1985-08-28 SE SE8504014A patent/SE464083B/sv not_active IP Right Cessation
- 1985-08-28 PH PH32711A patent/PH22813A/en unknown
- 1985-08-28 NO NO853390A patent/NO169711C/no not_active IP Right Cessation
- 1985-08-28 AT AT0251585A patent/AT391694B/de not_active IP Right Cessation
- 1985-08-28 DK DK391485A patent/DK162888C/da not_active IP Right Cessation
- 1985-08-28 ES ES546482A patent/ES8705372A1/es not_active Expired
- 1985-08-28 PT PT81041A patent/PT81041B/pt not_active IP Right Cessation
- 1985-08-28 GB GB08521358A patent/GB2163746B/en not_active Expired
- 1985-08-28 IE IE211885A patent/IE58788B1/en not_active IP Right Cessation
- 1985-08-29 JP JP60188723A patent/JPH0764817B2/ja not_active Expired - Lifetime
- 1985-08-29 NL NL8502374A patent/NL193583C/nl not_active IP Right Cessation
1986
- 1986-02-17 ES ES552399A patent/ES8800158A1/es not_active Expired
1992
- 1992-07-17 BG BG96645A patent/BG60401B1/xx unknown
1995
- 1995-01-17 JP JP7020913A patent/JPH0825879B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DK391485D0 (da)	1985-08-28
PH22813A (en)	1988-12-27
NL193583C (nl)	2000-03-02
JPS6160657A (ja)	1986-03-28
IE58788B1 (en)	1993-11-17
ES546482A0 (es)	1987-05-01
ATA251585A (de)	1990-05-15
KR920007269B1 (ko)	1992-08-29
NO169711C (no)	1992-07-29
AU4663685A (en)	1986-03-06
IT1190385B (it)	1988-02-16
NL8502374A (nl)	1986-03-17
NO169711B (no)	1992-04-21
NO853390L (no)	1986-03-03
DK162888B (da)	1991-12-23
PT81041A (en)	1985-09-01
ES552399A0 (es)	1987-11-01
DE3530046A1 (de)	1986-03-13
GB2163746A (en)	1986-03-05
AU582381B2 (en)	1989-03-23
DE3530046C2 (de)	1997-12-04
SE8504014D0 (sv)	1985-08-28
HUT38317A (en)	1986-05-28
JPH0825879B2 (ja)	1996-03-13
IL76176A (en)	1989-02-28
PT81041B (pt)	1988-01-22
GB8521358D0 (en)	1985-10-02
FI83511C (fi)	1991-07-25
KR870002078A (ko)	1987-03-30
AR244209A1 (es)	1993-10-29
LU86049A1 (de)	1986-09-11
US4764522A (en)	1988-08-16
DK391485A (da)	1986-03-01
IT8521865A0 (it)	1985-08-05
BE903110A (fr)	1986-02-24
FI83511B (fi)	1991-04-15
FI853140L (fi)	1986-03-01
GB2163746B (en)	1988-06-22
HU197309B (en)	1989-03-28
DK162888C (da)	1992-05-11
FR2569694A1 (fr)	1986-03-07
NL193583B (nl)	1999-11-01
IL76176A0 (en)	1985-12-31
BG96645A (bg)	1993-12-24
ES8705372A1 (es)	1987-05-01
SE8504014L (sv)	1986-03-01
JPH0764817B2 (ja)	1995-07-12
MC1696A1 (fr)	1986-07-18
IE852118L (en)	1986-02-28
AT391694B (de)	1990-11-12
ES8800158A1 (es)	1987-11-01
NZ213193A (en)	1989-10-27
SE464083B (sv)	1991-03-04
JPH07300417A (ja)	1995-11-14
FR2569694B1 (fr)	1991-05-03
BG60401B1 (en)	1995-02-28
GR852071B (fi)	1985-12-24
CA1261335A (en)	1989-09-26

Publication	Publication Date	Title
DE3581430D1 (de)	1991-02-28	Detergens.
FI851587A0 (fi)	1985-04-22	Foerfarande foer temperaturoevervakning.
DE3581707D1 (de)	1991-03-14	Neigungsmesser.
FI850434L (fi)	1985-08-04	Regleringsventil.
FI77959B (fi)	1989-02-28	Hushaolls- eller motsvarande koeksanordning.
FI853140L (fi)	1986-03-01	Etylendiaminmonoamid-derivat.
DE3578421D1 (de)	1990-08-02	Glycidyloxydiketone.
DE3582060D1 (de)	1991-04-11	Homopropargylamine.
FI73926B (fi)	1987-08-31	Standardhastighetsregulator foer motorfordon.
FI853974A0 (fi)	1985-10-14	Tillsatsmedel foer tvaettmedel.
DE3577708D1 (de)	1990-06-21	Diphenylhexafluorpropanabkoemmlinge.
DE3584628D1 (de)	1991-12-12	Xenocoumacine.
DE3586085D1 (de)	1992-06-25	Antitumor-4-hydroxy-2-zyklopentenonen.
FI840466A7 (fi)	1985-08-07	Lyftkil.
FI80907B (fi)	1990-04-30	Kraftunderstoedd hudappliseringsapparat.
DE3579862D1 (de)	1990-10-31	Mikrorechner.
FI854289A0 (fi)	1985-10-31	Roterande torkningstrumma.
DE3587711D1 (de)	1994-02-10	Minaktivin.
EP0177574A4 (en)	1987-08-03	Aminocarnitines.
FI83368B (fi)	1991-03-15	Handelvapen.
FI863025A7 (fi)	1986-07-23	Mikrostroembrytare.
DE3576291D1 (de)	1990-04-12	Entaester.
FI844452A0 (fi)	1984-11-13	Positionsindikator.
DE3587308D1 (de)	1993-06-03	Monobactame.
DE3585189D1 (de)	1992-02-27	Alpha-d-mannosidase hemmungsmittel.

Legal Events

Date	Code	Title	Description
2004-08-31	FG	Patent granted	Owner name: F. HOFFMANN-LA ROCHE AG
2005-02-28	MA	Patent expired